- United States
- /
- Aerospace & Defense
- /
- NYSE:NOC
Northrop Grumman Corporation (NYSE:NOC) Shares Could Be 33% Below Their Intrinsic Value Estimate
Key Insights
- Northrop Grumman's estimated fair value is US$671 based on 2 Stage Free Cash Flow to Equity
- Northrop Grumman is estimated to be 33% undervalued based on current share price of US$451
- Analyst price target for NOC is US$486 which is 28% below our fair value estimate
Today we will run through one way of estimating the intrinsic value of Northrop Grumman Corporation (NYSE:NOC) by projecting its future cash flows and then discounting them to today's value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Believe it or not, it's not too difficult to follow, as you'll see from our example!
Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.
View our latest analysis for Northrop Grumman
Is Northrop Grumman Fairly Valued?
We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value:
10-year free cash flow (FCF) estimate
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF ($, Millions) | US$2.41b | US$3.02b | US$3.37b | US$3.57b | US$3.89b | US$4.14b | US$4.35b | US$4.53b | US$4.70b | US$4.85b |
Growth Rate Estimate Source | Analyst x13 | Analyst x13 | Analyst x10 | Analyst x4 | Analyst x3 | Est @ 6.29% | Est @ 5.09% | Est @ 4.25% | Est @ 3.66% | Est @ 3.25% |
Present Value ($, Millions) Discounted @ 6.1% | US$2.3k | US$2.7k | US$2.8k | US$2.8k | US$2.9k | US$2.9k | US$2.9k | US$2.8k | US$2.8k | US$2.7k |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = US$28b
The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.3%. We discount the terminal cash flows to today's value at a cost of equity of 6.1%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = US$4.9b× (1 + 2.3%) ÷ (6.1%– 2.3%) = US$132b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$132b÷ ( 1 + 6.1%)10= US$73b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$101b. In the final step we divide the equity value by the number of shares outstanding. Compared to the current share price of US$451, the company appears quite good value at a 33% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
The Assumptions
The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Northrop Grumman as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.1%, which is based on a levered beta of 0.820. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Northrop Grumman
- Debt is well covered by earnings and cashflows.
- Dividends are covered by earnings and cash flows.
- Earnings declined over the past year.
- Dividend is low compared to the top 25% of dividend payers in the Aerospace & Defense market.
- Annual earnings are forecast to grow for the next 3 years.
- Trading below our estimate of fair value by more than 20%.
- Annual earnings are forecast to grow slower than the American market.
Moving On:
Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. Can we work out why the company is trading at a discount to intrinsic value? For Northrop Grumman, there are three relevant elements you should look at:
- Risks: You should be aware of the 2 warning signs for Northrop Grumman we've uncovered before considering an investment in the company.
- Future Earnings: How does NOC's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NYSE every day. If you want to find the calculation for other stocks just search here.
Valuation is complex, but we're here to simplify it.
Discover if Northrop Grumman might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:NOC
Northrop Grumman
Operates as an aerospace and defense technology company in the United States, Asia/Pacific, Europe, and internationally.
Established dividend payer with adequate balance sheet.